Bixiye
Topiramate ER - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2025
Natiijooyinka Raadinta
Soo bandhiga 4021 - 4030 ee natiijooyinka 4132
Bixiye
Proton Pump Inhibitors (PPIs) - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2025
Bixiye
Rayos - Commercial
Oggolaanshaha Hore
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2025
Bixiye
Sucraid (sacrosidase) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2025
Bixiye
Sucraid (sacrosidase) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2025
Bixiye
Proton Pump Inhibitors (PPIs) - Medicaid
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2025
Bixiye
Sohonos - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2025
Bixiye
QP113-25 Use of the TS Modifier
Taariikhda uu dhaqangalayo Barnaamijka: Des 24, 2025
Bixiye
QP112-25 Prior Authorization for Ongoing Treatment of Chronic Conditions
Taariikhda uu dhaqangalayo Barnaamijka: Des 24, 2025
Bixiye
QP111-25 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda uu dhaqangalayo Barnaamijka: Des 24, 2025